Former U.S. House Speaker Newt Gingrich (R-GA) extolled the therapeutic promise of ibogaine on a recent episode of his podcast, drawing attention to a Stanford University study that found the psychedelic showed potential to treat PTSD, anxiety and depression in military veterans with traumatic brain injury.
“This could be one of the great breakthroughs of the next 10 or 15 years,” he said on the episode of Newt World that aired last month.
Gingrich, ...
The Texas legislature has passed a bill that would create a state-backed research consortium to conduct clinical trials on ibogaine as a possible treatment for substance use disorders and other mental health conditions, with the goal of developing a drug that would win U.S. Food and Drug Administration (FDA) approval.
The state would retain a commercial interest in “all intellectual property that may be generated over the course of the drug development clinical ...
Drug policy reform advocates, public health experts and current and former government officials met for a summit in Colorado over the weekend to discuss how to move forward with state-led clinical research into ibogaine as a treatment for addiction, trauma and various neurodegenerative conditions.
Attendees at the three-day Aspen Ibogaine Meeting discussed science and policy around the plant-based psychedelic as well as how to go about building the necessary financial and legal infrastructure ...